
Bijan Ahvazi
Examiner (ID: 16926, Phone: (571)270-3449 , Office: P/1763 )
| Most Active Art Unit | 1763 |
| Art Unit(s) | 1763, 4171, 1761, 1796 |
| Total Applications | 1549 |
| Issued Applications | 974 |
| Pending Applications | 113 |
| Abandoned Applications | 482 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5552840
[patent_doc_number] => 20090286826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS HAVING CARBOXYVINYL POLYMER AND POVIDONE POLYMER'
[patent_app_type] => utility
[patent_app_number] => 12/464194
[patent_app_country] => US
[patent_app_date] => 2009-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4010
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286826.pdf
[firstpage_image] =>[orig_patent_app_number] => 12464194
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/464194 | PHARMACEUTICAL COMPOSITIONS HAVING CARBOXYVINYL POLYMER AND POVIDONE POLYMER | May 11, 2009 | Abandoned |
Array
(
[id] => 5987245
[patent_doc_number] => 20110098312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'METHODS FOR PREVENTING THE DEVELOPMENT OF RETINOPATHY BY THE ORAL ADMINISTRATION OF NNR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 12/992115
[patent_app_country] => US
[patent_app_date] => 2009-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6392
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098312.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992115
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992115 | METHODS FOR PREVENTING THE DEVELOPMENT OF RETINOPATHY BY THE ORAL ADMINISTRATION OF NNR LIGANDS | May 10, 2009 | Abandoned |
Array
(
[id] => 6497838
[patent_doc_number] => 20100286156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Collyrium For The Treatment Of Conical Cornea With Cross-Linking Trans-Epithelial Technique'
[patent_app_type] => utility
[patent_app_number] => 12/436355
[patent_app_country] => US
[patent_app_date] => 2009-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 493
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286156.pdf
[firstpage_image] =>[orig_patent_app_number] => 12436355
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/436355 | Collyrium For The Treatment Of Conical Cornea With Cross-Linking Trans-Epithelial Technique | May 5, 2009 | Abandoned |
Array
(
[id] => 6202035
[patent_doc_number] => 20110064821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'ENCAPSULATION OF BIOLOGICALLY ACTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/991556
[patent_app_country] => US
[patent_app_date] => 2009-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10923
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20110064821.pdf
[firstpage_image] =>[orig_patent_app_number] => 12991556
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/991556 | ENCAPSULATION OF BIOLOGICALLY ACTIVE AGENTS | May 4, 2009 | Abandoned |
Array
(
[id] => 9355404
[patent_doc_number] => 08673937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Eye-drop preparation and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/988895
[patent_app_country] => US
[patent_app_date] => 2009-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2981
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988895
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/988895 | Eye-drop preparation and use thereof | Apr 22, 2009 | Issued |
Array
(
[id] => 6302138
[patent_doc_number] => 20100068167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Low Salt Forms of Polyallylamine'
[patent_app_type] => utility
[patent_app_number] => 12/427127
[patent_app_country] => US
[patent_app_date] => 2009-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2252
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068167.pdf
[firstpage_image] =>[orig_patent_app_number] => 12427127
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/427127 | Low salt forms of polyallylamine | Apr 20, 2009 | Issued |
Array
(
[id] => 5570426
[patent_doc_number] => 20090253804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'METHOD FOR TREATING OR PREVENTING DRY EYE DISORDERS USING ALKYLAMINO-POLYHYDROXYALKANES'
[patent_app_type] => utility
[patent_app_number] => 12/420374
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3253
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253804.pdf
[firstpage_image] =>[orig_patent_app_number] => 12420374
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/420374 | Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes | Apr 7, 2009 | Issued |
Array
(
[id] => 5343319
[patent_doc_number] => 20090181969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Hypotensive Lipid And Timolol Compositions And Methods Of Using Same'
[patent_app_type] => utility
[patent_app_number] => 12/408125
[patent_app_country] => US
[patent_app_date] => 2009-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5314
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181969.pdf
[firstpage_image] =>[orig_patent_app_number] => 12408125
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/408125 | Hypotensive lipid and timolol compositions and methods of using same | Mar 19, 2009 | Issued |
Array
(
[id] => 5570283
[patent_doc_number] => 20090253661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'OCULAR AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/407175
[patent_app_country] => US
[patent_app_date] => 2009-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3878
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253661.pdf
[firstpage_image] =>[orig_patent_app_number] => 12407175
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/407175 | OCULAR AGENTS | Mar 18, 2009 | Abandoned |
Array
(
[id] => 5400926
[patent_doc_number] => 20090236239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'SOFT CONTACT LENS PACKAGE PRODUCT AND METHOD OF PACKAGING SOFT CONTACT LENS'
[patent_app_type] => utility
[patent_app_number] => 12/404565
[patent_app_country] => US
[patent_app_date] => 2009-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8277
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20090236239.pdf
[firstpage_image] =>[orig_patent_app_number] => 12404565
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/404565 | SOFT CONTACT LENS PACKAGE PRODUCT AND METHOD OF PACKAGING SOFT CONTACT LENS | Mar 15, 2009 | Abandoned |
Array
(
[id] => 6007895
[patent_doc_number] => 20110059926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'Vitamin D Compounds and Methods for Reducing Ocular Hypertension (OHT)'
[patent_app_type] => utility
[patent_app_number] => 12/921497
[patent_app_country] => US
[patent_app_date] => 2009-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15367
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059926.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921497
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921497 | Vitamin D compounds and methods for reducing ocular hypertension (OHT) | Mar 9, 2009 | Issued |
Array
(
[id] => 6636836
[patent_doc_number] => 20100226999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'PROCESS FOR FORMING STABILIZED OPHTHALMIC SOLUTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/399647
[patent_app_country] => US
[patent_app_date] => 2009-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3672
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20100226999.pdf
[firstpage_image] =>[orig_patent_app_number] => 12399647
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/399647 | PROCESS FOR FORMING STABILIZED OPHTHALMIC SOLUTIONS | Mar 5, 2009 | Abandoned |
Array
(
[id] => 13914905
[patent_doc_number] => 10201548
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Methods for treating ocular inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 12/399729
[patent_app_country] => US
[patent_app_date] => 2009-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7796
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12399729
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/399729 | Methods for treating ocular inflammatory diseases | Mar 5, 2009 | Issued |
Array
(
[id] => 8956026
[patent_doc_number] => 08501800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-06
[patent_title] => 'Controlled-release ophthalmic vehicles'
[patent_app_type] => utility
[patent_app_number] => 12/398625
[patent_app_country] => US
[patent_app_date] => 2009-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10783
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12398625
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/398625 | Controlled-release ophthalmic vehicles | Mar 4, 2009 | Issued |
Array
(
[id] => 5404522
[patent_doc_number] => 20090239836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Multifunctional Ophthalmic Compositions'
[patent_app_type] => utility
[patent_app_number] => 12/398202
[patent_app_country] => US
[patent_app_date] => 2009-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7507
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239836.pdf
[firstpage_image] =>[orig_patent_app_number] => 12398202
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/398202 | Multifunctional Ophthalmic Compositions | Mar 4, 2009 | Abandoned |
Array
(
[id] => 5532975
[patent_doc_number] => 20090232763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 12/396680
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8179
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232763.pdf
[firstpage_image] =>[orig_patent_app_number] => 12396680
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/396680 | AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES | Mar 2, 2009 | Abandoned |
Array
(
[id] => 5992641
[patent_doc_number] => 20110014294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'STIMULATION OF OCULAR RETROBULBAR BLOOD FLOW USING OCULAR IRRITANTS'
[patent_app_type] => utility
[patent_app_number] => 12/920458
[patent_app_country] => US
[patent_app_date] => 2009-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7362
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014294.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920458
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920458 | STIMULATION OF OCULAR RETROBULBAR BLOOD FLOW USING OCULAR IRRITANTS | Mar 1, 2009 | Abandoned |
Array
(
[id] => 6136438
[patent_doc_number] => 20110009376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'PROPHYLACTIC OR THERAPEUTIC AGENT FOR EYE DISEASE ACCOMPANIED BY OPTIC NERVE DISORDER'
[patent_app_type] => utility
[patent_app_number] => 12/919462
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5325
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009376.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919462
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919462 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR EYE DISEASE ACCOMPANIED BY OPTIC NERVE DISORDER | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5404528
[patent_doc_number] => 20090239842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Solutions containing epinastin'
[patent_app_type] => utility
[patent_app_number] => 12/394684
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1575
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239842.pdf
[firstpage_image] =>[orig_patent_app_number] => 12394684
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/394684 | Solutions containing epinastin | Feb 26, 2009 | Abandoned |
Array
(
[id] => 10076235
[patent_doc_number] => 09114070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-25
[patent_title] => 'Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye'
[patent_app_type] => utility
[patent_app_number] => 12/919807
[patent_app_country] => US
[patent_app_date] => 2009-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 8067
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12919807
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919807 | Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye | Feb 25, 2009 | Issued |